Search
ubiquitin C-terminal hydrolase in blood
Indications:
- assessment of need for CT of brain in adults with mild traumatic brain injury (concussion)
Clinical significance:
- released from the brain into blood
- can be measured within 12 hours of head injury
Method:
- 3-4-hour turnaround time
Related
glial fibrillary acidic protein (GFAP) in blood/plasma/serum
ubiquitin C-terminal hydrolase; UCH; ubiquitin thiolesterase; ubiquitin-specific processing protease; deubiquitinating enzyme
General
special chemistry test
References
- Brooks M
FDA Clears First Blood Test to Aid in Concussion Diagnosis.
Medscape - Feb 14, 2018.
https://www.medscape.com/viewarticle/892683
- FDA News Release. Feb 14, 2018
FDA authorizes marketing of first blood test to aid in the
evaluation of concussion in adults.
https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm596531.htm